A Role for Glutathione in the Pathophysiology of Bipolar Disorder and Schizophrenia? Animal Models and Relevance to Clinical Practice

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|16|23|2965-2976

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.23, 2009-08, pp. : 2965-2976

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania

By Tarazi Frank I   Neill Jo C  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 1, 2013-01 ,pp. : 93-103

Informa Healthcare

Access to resources Recommend Favorite

The Management of Individuals with Bipolar Disorder: A Review of the Evidence and its Integration into Clinical Practice

By Malhi Gin S.   Adams Danielle   Cahill Catherine M.   Dodd Seetal   Berk Michael  

Drugs, Vol. 69, Iss. 15, 2009-10 ,pp. : 2063-2101

Adis International

Access to resources Recommend Favorite

Glutamatergic Animal Models of Schizophrenia

By  

Current Pharmaceutical Design, Vol. 18, Iss. 12, 2012-04 ,pp. : 1593-1604

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Dysfunction in the Pathophysiology of Bipolar Disorder: Effects of Pharmacotherapy

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 5, 2015-08 ,pp. : 355-365

Bentham Science Publishers

Access to resources Recommend Favorite

Guide for better practice in bipolar disorder

By  

Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite